Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from UiPath

IBD Rating Upgrades: UiPath Flashes Improved Price Strength

A Relative Strength Rating upgrade for UiPath shows improving technical performance. Will it continue?

Investors Business Daily

Stocks With Rising Relative Strength: UiPath

UiPath shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Top Tech M&A 2025: The Prospects We're Watching

High interest rates and economic uncertainty have dimmed the market for big M&A tech deals, but the tides could be turning.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Breakout Stocks With the Potential to Skyrocket This Year

Looking for high-potential breakout stocks to supercharge your returns? You’re not alone. With volatility and innovation shaking the markets in 2025, the smartest investors are eyeing companies with strong momentum and growth catalysts. From AI juggernauts to EV innovators and fintech disruptors, we’ve identified five breakout stocks that may be…

Clever Dude

Stocks With Rising Relative Strength: UiPath

A Relative Strength Rating upgrade for UiPath shows improving technical performance. Will it continue?

Investors Business Daily

3 Mid-Cap Stocks Turning Heads in AI, Automation, & Cybersecurity

These mid-cap tech names may have the potential to foster robust innovation while enjoying a bit more stability than smaller firms in the sector.

MarketBeat

Stock Market Today: Dow Jones Gains After Inflation Surprise, Nvidia, Tesla Rally As Cathie Wood Loads Up On Defense Stock (Live Coverage)

Dow Jones fell but other indexes gained after signs of cooling inflation in the stock market today.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

2 Growth Stocks Under $50 to Buy and Hold for the Long Term

These companies have the ability to grow your portfolio, as long as you commit to them for the long haul.

Barchart

Is UiPath Leading the Next Wave of Automation Innovation?

As automation evolves beyond repetitive tasks, UiPath Inc. (PATH) is stepping up with AI-driven solutions that adapt and learn on the go. With its innovative approach and growing market presence, can it stay ahead in the fast-moving world of intelligent automation? Read on to find out.

StockNews.com

Cathie Wood Is Dumping This AI Stock. Should You?

UiPath’s strong Q3 results and AI agent launch are reasons for optimism, but its persistent losses and volatility call for a cautious stance.

Barchart

Businesses are keen to embrace AI agents, but still struggle to start

Agentic AI promises to deliver even more productivity-boosting automation, but there are some challenges.

TechRadar

Is UiPath a Buy After Its Recent Market Correction?

UiPath, with innovative product offerings, strategic initiatives, and impressive financial standings, looks poised for long-term growth. However, considering the recent market correction, is it a buy today? Read more to find out.

StockNews.com

3 AI & Data Analytics Stocks Turning Information into Profit

The AI and data analytics market is experiencing significant growth, driven by growing demand for analytics tools and technological advancements. Thus, it could be wise to buy and hold top AI and data analytics stocks Accenture (ACN), Autodesk (ADSK), and UiPath (PATH) for significant profits. Continue reading.

StockNews.com

Top 3 High-Risk, High-Reward Plays for Bullish Investors

The January effect often leaves investors feeling optimistic to start a new year: these three high-risk, high-reward stock plays may appeal to bulls.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

1 Growth Stock to Buy Under $20 for Upside of 45%

The global trend toward automation may help this robotics stock win big.

MarketBeat

Top 3 Robotics and Automation Stocks for the Next AI Boom

The next wave of AI will include interactive and autonomous AI and these three companies are making inroads into these areas today

MarketBeat

UiPath: A Golden Opportunity in AI-Driven Workflow Automation

UiPath's beat-and-raise quarter keeps the company on track to double earnings over the next few years as it dominates workflow automation.

MarketBeat

Trash to Treasure: 3 Tax-Loss Stocks Set for a January Rebound

Unity, Walgreens, and UiPath stocks are down but could rebound in January as tax loss selling fades. Learn why these stocks are worth watching.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

UiPath 'Story Remains A Work In Progress': Analysts Want To See More After Q3 Results, 'Sustained Execution Remains Key'

Analysts see near-term concerns for UiPath after the company's Q3 results.

Benzinga

Analyst Scoreboard: 2 Ratings For UiPath

Analysts' ratings for UiPath (NYSE:PATH) over the last quarter vary from bullish to bearish, as provided by 2 analysts.

Investors Business Daily

Dow Jones Futures: Bitcoin Below $100K, Jobs Report Due; When To Sell 'Heat' Stocks

The market is near highs with the jobs report due. Bitcoin couldn't hold $100,000. When should investors sell "heat" stocks?

Benzinga

GitLab's Earnings: A Preview

GitLab (NASDAQ:GTLB) is preparing to release its quarterly earnings on Thursday, 2024-12-05. Here's a brief overview of what investors should keep in mind before the announcement.

Benzinga

A Peek at UiPath's Future Earnings

UiPath (NYSE:PATH) will release its quarterly earnings report on Thursday, 2024-12-05. Here's a brief overview for investors ahead of the announcement.

Benzinga

Insights into SentinelOne's Upcoming Earnings

SentinelOne (NYSE:S) is set to give its latest quarterly earnings report on Wednesday, 2024-12-04. Here's what investors need to know before the announcement.

StockNews.com

Is UiPath a Hidden Gem in the Automation Sector?

UiPath’s (PATH) continued growth is fueled by solid demand for its innovative product offerings, strategic innovations, and optimistic analysts’ expectations. So, let’s analyze whether PATH is a buy today. Read more to find out.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.